trending Market Intelligence /marketintelligence/en/news-insights/trending/s8s9iz_zp_rkqzer7dhxdw2 content esgSubNav
In This List

Oncobiologics names director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Oncobiologics names director

Oncobiologics Inc. appointed Joerg Windisch as director, effective March 23.

He was appointed to fill the vacancy created by Yezan Haddadin's resignation from the board, the company said March 27 in an SEC filing.

Windisch is currently COO of Polpharma Biologics.

Cranbury, N.J.-based Oncobiologics is a clinical-stage biopharmaceutical company which focuses on developing biosimilars in immunology and oncology disease areas.